Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Force

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Journal of the American College of Cardiology|February 15, 2005
Highlights of the 2004 scientific sessions of the Heart Failure Society of America, Toronto, Canada, September 12 to 15, 2004Peter Liu, Marvin A Konstam, Thomas Force
Circulation|July 2, 2008
Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeuticsMing Hui Chen, Risto Kerkelä, Thomas Force
Circulation|January 30, 2002
Apoptosis signal-regulating kinase/nuclear factor-kappaB: a novel signaling pathway regulates cardiomyocyte hypertrophyThomas Force, Syed Haq, Heiko Kilter, et al.
Journal of Molecular and Cellular Cardiology|December 18, 2010
Targeting GSK-3 family members in the heart: a very sharp double-edged swordHui Cheng, James Woodgett, Mia Maamari, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2014
Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac diseaseHind Lal, Firdos Ahmad, Shan Parikh, et al.
Circulation Research|January 2, 2015
The GSK-3 family as therapeutic target for myocardial diseasesHind Lal, Firdos Ahmad, James Woodgett, et al.
Journal of Cardiac Failure|January 30, 2003
Stretch-activated pathways and left ventricular remodelingThomas Force, Ashour Michael, Heiko Kilter, et al.
Drug Discovery Today. Disease Mechanisms|February 1, 2011
Developing small molecules to inhibit kinases unkind to the heart: p38 MAPK as a case in pointMichael S Marber, Jeffery D Molkentin, Thomas Force
Circulation Research|July 9, 2016
Response by Zhou et al to Letter Regarding Article, "Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy"Jibin Zhou, Firdos Ahmad, Hind Lal, et al.
Nature Reviews. Cancer|April 26, 2007
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibitionThomas Force, Daniela S Krause, Richard A Van Etten
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Journal of the American College of Cardiology|February 15, 2005
Highlights of the 2004 scientific sessions of the Heart Failure Society of America, Toronto, Canada, September 12 to 15, 2004Peter Liu, Marvin A Konstam, Thomas Force
Circulation|July 2, 2008
Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeuticsMing Hui Chen, Risto Kerkelä, Thomas Force
Circulation|January 30, 2002
Apoptosis signal-regulating kinase/nuclear factor-kappaB: a novel signaling pathway regulates cardiomyocyte hypertrophyThomas Force, Syed Haq, Heiko Kilter, et al.
Journal of Molecular and Cellular Cardiology|December 18, 2010
Targeting GSK-3 family members in the heart: a very sharp double-edged swordHui Cheng, James Woodgett, Mia Maamari, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2014
Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac diseaseHind Lal, Firdos Ahmad, Shan Parikh, et al.
Circulation Research|January 2, 2015
The GSK-3 family as therapeutic target for myocardial diseasesHind Lal, Firdos Ahmad, James Woodgett, et al.
Journal of Cardiac Failure|January 30, 2003
Stretch-activated pathways and left ventricular remodelingThomas Force, Ashour Michael, Heiko Kilter, et al.
Drug Discovery Today. Disease Mechanisms|February 1, 2011
Developing small molecules to inhibit kinases unkind to the heart: p38 MAPK as a case in pointMichael S Marber, Jeffery D Molkentin, Thomas Force
Circulation Research|July 9, 2016
Response by Zhou et al to Letter Regarding Article, "Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy"Jibin Zhou, Firdos Ahmad, Hind Lal, et al.
Nature Reviews. Cancer|April 26, 2007
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibitionThomas Force, Daniela S Krause, Richard A Van Etten
Pageof 11